Vanguard Capital Management’s Century Therapeutics IPSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.7M Sell
5,692,587
-11,093
-0.2% -$22.7K ﹤0.01% 2771
2026
Q2
$14M Buy
5,703,680
+17,476
+0.3% +$39.9K ﹤0.01% 2631
2026
Q1
$12.9M Buy
+5,686,204
New +$12M ﹤0.01% 2593

Other funds holding IPSC

Vanguard Capital Management's IPSC Position: Q3 2026 in Review

Vanguard Capital Management reduced its Century Therapeutics (IPSC) stake by 0.19% in Q3 2026, selling an estimated $22.7K and leaving 5,692,587 shares worth $9.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2771.

Vanguard Capital Management first reported a position in IPSC in Q1 2026 and has held it in 3 quarters since. The position peaked at $14M in Q2 2026. 102 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.

  • Vanguard Capital Management held 5,692,587 shares of Century Therapeutics worth $9.7M as of Q3 2026.
  • Vanguard Capital Management sold 11,093 Century Therapeutics shares in Q3 2026, an estimated $22.7K.
  • Century Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2771 holding.
  • Vanguard Capital Management first reported a position in Century Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Century Therapeutics position peaked at $14M in Q2 2026.
  • 102 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.